Literature DB >> 21915665

[Ductal and lobular preneoplasia: role in breast cancer development].

S Aulmann1.   

Abstract

BACKGROUND: With the widespread use of screening mammography and core needle biopsies, preneoplastic lesions of the breast are observed with increasing frequency. Unlike low-grade ductal carcinoma in situ (lg-DCIS), a possible precursor role of atypical ductal hyperplasia (ADH), lobular neoplasia (LN), and flat epithelial atypia (FEA) as well as their risk of progression have not been clearly defined. The aim of the present study was to evaluate the biological potential of these early low-grade lesions in the development of breast cancer.
MATERIALS AND METHODS: Different series of precursor lesions and syn- or metachronous invasive carcinomas were tested for clonality using mitochondrial DNA sequencing, analysis of E-cadherin inactivation and comparative allelotyping with a panel of 14 polymorphous STR markers.
RESULTS: In a series of invasive carcinomas occurring up to 10 years after the initial diagnosis of lobular neoplasia, a direct (clonal) association was established between LN and 3 of 5 invasive lobular cancers (ILC) but not in any of the cases with ductal secondary tumors. Tests on lg-DCIS and FEA occurring in association with tubular breast carcinomas demonstrated a direct clonal relationship in 67 and 70% of cases, respectively, and comparative allelotyping revealed a high degree of homology in the patterns of chromosomal imbalances. In addition, FEA and lg-DCIS, but not LN, were frequently closely related with each other.
CONCLUSION: The present data provide molecular evidence for a direct clonal relationship of LN and ILC as well as of FEA and lg-DCIS with tubular breast carcinomas. However, the multifocal occurrence and frequent coexistence of the different precursor lesions suggests the presence of (possibly hormone-induced) field effects on the breast parenchyma.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21915665     DOI: 10.1007/s00292-011-1472-9

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  9 in total

1.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years.

Authors:  P P Rosen; C Kosloff; P H Lieberman; F Adair; D W Braun
Journal:  Am J Surg Pathol       Date:  1978-09       Impact factor: 6.394

3.  Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer.

Authors:  Sebastian Aulmann; Roland Penzel; Thomas Longerich; Benjamin Funke; Peter Schirmacher; Hans Peter Sinn
Journal:  Breast Cancer Res Treat       Date:  2007-03-23       Impact factor: 4.872

4.  Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast.

Authors:  Luca Morandi; Gianluca Marucci; Maria P Foschini; Maria G Cattani; Annalisa Pession; Cristina Riva; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

5.  Invasive tubular carcinoma of the breast frequently is clonally related to flat epithelial atypia and low-grade ductal carcinoma in situ.

Authors:  Sebastian Aulmann; Zeinab Elsawaf; Roland Penzel; Peter Schirmacher; Hans Peter Sinn
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

6.  [Clonal association of flat epithelial atypia and tubular breast cancer].

Authors:  S Aulmann; Z Elsawaf; R Penzel; P Schirmacher; H P Sinn
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

7.  C-myc oncogene amplification in ductal carcinoma in situ of the breast.

Authors:  Sebastian Aulmann; Martin Bentz; Hans Peter Sinn
Journal:  Breast Cancer Res Treat       Date:  2002-07       Impact factor: 4.872

8.  Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.

Authors:  D L Page; T E Kidd; W D Dupont; J F Simpson; L W Rogers
Journal:  Hum Pathol       Date:  1991-12       Impact factor: 3.466

9.  The Jalview Java alignment editor.

Authors:  Michele Clamp; James Cuff; Stephen M Searle; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2004-01-22       Impact factor: 6.937

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.